Fonar's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Fonar's ROA in the third quarter of 2026?
Fonar Corporation achieved a return on average assets (ROA) of 3.91 % in its third quarter of 2026, which is below Fonar's average return on assets, which stands at 15.12%.

ROA decreased relative to the period ending Dec 31 2025, due to the decline in net income.

However, within the Healthcare sector 173 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2026 quarter, so far to 1394, from total ROA ranking in the second quarter of 2026 at 1534.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter	(Jun 30 2025) IV. Quarter	(Mar 31 2025) III. Quarter
Y / Y Total Assets Change	2 %	4.46 %	2.86 %	1.24 %	2.52 %
Y / Y Net Income Change	-24.99 %	22.01 %	-33.25 %	-32.97 %	19.41 %
Net Income (TTM) in million	9	9	9	10	11
Return On Assets (TTM)	3.91 %	4.27 %	4.11 %	4.76 %	5.03 %
FONR's Total Ranking	# 1394	# 1534	# 1337	# 1229	# 1194
Total Assets (TTM) in million	219	217	218	217	215
Seq. Total Assets Change	0.92 %	-0.52 %	0.67 %	0.92 %	3.35 %
Seq. Net Income Change	-12.41 %	-4.91 %	143.72 %	-63.05 %	42.48 %

FONR's 5 Years Annual ROA >> Back to FONR Management Effectiveness >> Compare FONR ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 51
Sector	# 174
Overall	# 1387

Return On Assets Statistics
High	Average	Low
27.43 %	15.12 %	3.91 %
(Mar 31 2017)		(Mar 31 2026)

Financial Statements
Fonar's Assets	$ 219 million	FONR's Balance sheet
Fonar's Income	$ 2 million	Quarterly FONR's Income Statement
FONR's Income by Division		See FONR's Income by Division

Annual Return On Assets	(Jun 30 2025) FY 2025	(Jun 30 2024) FY 2024	(Jun 30 2023) FY 2023	(Jun 30 2022) FY 2022	(Jun 30 2021) FY 2021
Y / Y Total Assets Change	1.24 %	6.81 %	0.62 %	5.19 %	5.13 %
Total Assets in million	217	214	201	199	190
Y / Y Net Income Change	-28.06 %	16.25 %	-29.64 %	26.04 %	16.82 %
Net Income in million	10	14	12	17	14
Annual Return On Assets	4.68 %	6.58 %	6.05 %	8.65 %	7.22 %

FONR's 5 Years Annual ROA >> Back to FONR Management Effectiveness >> Compare FONR ROA to its Competitors

Comment on FONR's ROA in the fiscal year ending 2025

In the fiscal year 2025 Fonar's ROA decreased compared to previous year to 4.68 %, due to deterioration of net income -28.06 % to $10.14 million, from $14.10 million a year ago, as FONR's assets were $216.91 million.

More Return On Assets Ratios
FONR's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
FONR's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for FONR's Competitors
Subscribers only: Roa for Fonar's Suppliers
Subscribers only: Return On Assets for FONR's Customers

You may also want to know
FONR's Roi	FONR's Inventory Turnover Ratio	FONR's Growth Rates	FONR's Dividend Comparisons
	FONR's Profitability Ratios	FONR's Asset Turnover Ratio	FONR's Dividend Growth
FONR's Roe	FONR's Valuation Ratios	FONR's Financial Strength Ratios	FONR's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2026, within Healthcare Sector	ROA
Johnson and Johnson	10.70 %
Ufp Technologies Inc	10.49 %
Lemaitre Vascular Inc	10.31 %
Embecta Corp	10.25 %
Cryoport inc	10.07 %
Universal Health Services Inc	10.06 %
Solventum Corporation	9.97 %
Kiniksa Pharmaceuticals International Plc	9.86 %
Mimedx Group Inc	9.73 %
Penumbra Inc	9.58 %
Pacific Health Care Organization Inc	9.57 %
Insulet Corporation	9.55 %
Progyny Inc	9.03 %
Siga Technologies Inc	8.94 %
Tenet Healthcare Corp	8.91 %
Utah Medical Products Inc	8.86 %
Amgen Inc	8.64 %
Lifevantage Corp	8.60 %
Entrada Therapeutics Inc	8.57 %
Lifemd Inc	8.49 %
Healthcare Services Group Inc	8.45 %
Boston Scientific Corporation	8.26 %
National Healthcare Corp	8.18 %
Edwards Lifesciences Corporation	8.13 %
Pediatrix Medical Group Inc	8.09 %
Nature s Sunshine Products inc	7.94 %
Infusystem Holdings Inc	7.93 %
Bristol myers Squibb Company	7.90 %
Viemed Healthcare Inc	7.85 %
Xoma Royalty Corporation	7.73 %

Date modified: 2026-06-22T14:32:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.